PROCTER & GAMBLE Co 4

Paul Gama, CEO – Health Care of Procter & Gamble, received routine stock and RSU-related share awards totaling about 7,734 shares of PG common stock with no open-market buying or selling.

On August 19, 2026, Paul Gama, CEO – Health Care of Procter & Gamble, received an award of 7,727 shares of common stock, including dividend-equivalent restricted stock units that will be settled in stock, increasing his direct ownership to 44,227.8803 shares, while 1,173.4717 shares are held indirectly through a retirement plan trustee. Separately, on August 17, 2026, he received an additional 7.0954 shares of common stock pursuant to Procter & Gamble’s 2025 Stock and Incentive Compensation Plan, reflecting routine dividend-equivalent stock awards tied to prior RSU grants and the company’s retirement program. Based on the current market price of approximately $143.38 per share, the newly awarded shares represent a modest incremental compensation value relative to his overall holdings, and the transactions appear to be standard equity-based compensation rather than open-market purchases or sales.

Filing Facts

CIK

80424

Ticker

PG

Form

4

Source Type

sec

Accession

0000080424-26-000135

Alert Tier

5